News And Announcements
Smiths Group sees organic growth accelerate in Q3
Smiths Group reported an acceleration in sales growth in the third quarter despite tough comparators with last year, as the engineering firm reaffirmed its growth expectations for the full year.
GSK reports promising results from asthma treatment trials
GSK announced promising results from phase three clinical trials evaluating the efficacy and safety of depemokimab in treating severe asthma with type 2 inflammation on Tuesday.
XP Power rejects £468m takeover proposal from Advanced Energy
Advanced Energy said on Tuesday that it has made three possible all-cash offers for XP Power, the last of which valued the group at £468m.
AstraZeneca lays out plans to hit $80bn in revenues by 2030
AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts significant growth from existing oncology, biopharmaceuticals and rare disease portfolios.
Kingfisher's LFL sales hit by France weakness
Home improvement retailer Kingfisher has said that first-quarter like-for-like sales were down on last year on the back of weakness in France, with the decline picking up pace early into the second quarter.